NK cells expressing NKG2D were slightly increased at baseline on CD56high/CD16− cells in melanoma patients, while on CD56lowCD16+ cells NKG2D was slightly reduced after DC vaccination (Fig. 3g,h, and i). Here, KLRK1 is linked to melanoma.